EFG International AG purchased a new position in Cigna Group (NYSE:CI – Free Report) during the second quarter, HoldingsChannel reports. The fund purchased 9,038 shares of the health services provider’s stock, valued at approximately $2,491,000.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Evercore Wealth Management LLC raised its position in shares of Cigna Group by 2.8% during the first quarter. Evercore Wealth Management LLC now owns 1,301 shares of the health services provider’s stock valued at $347,000 after buying an additional 35 shares during the last quarter. Cary Street Partners Investment Advisory LLC lifted its holdings in shares of Cigna Group by 11.0% in the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 363 shares of the health services provider’s stock worth $100,000 after buying an additional 36 shares in the last quarter. IHT Wealth Management LLC boosted its position in shares of Cigna Group by 2.5% during the fourth quarter. IHT Wealth Management LLC now owns 1,535 shares of the health services provider’s stock worth $423,000 after acquiring an additional 38 shares during the last quarter. Whetstone Capital Advisors LLC grew its stake in Cigna Group by 4.9% during the fourth quarter. Whetstone Capital Advisors LLC now owns 829 shares of the health services provider’s stock valued at $228,000 after acquiring an additional 39 shares in the last quarter. Finally, CYBER HORNET ETFs LLC grew its stake in Cigna Group by 5.3% during the fourth quarter. CYBER HORNET ETFs LLC now owns 801 shares of the health services provider’s stock valued at $220,000 after acquiring an additional 40 shares in the last quarter. 86.99% of the stock is currently owned by institutional investors.
Cigna Group Price Performance
CI stock opened at $281.01 on Thursday. Cigna Group has a 52 week low of $239.51 and a 52 week high of $315.47. The firm has a market capitalization of $74.25 billion, a P/E ratio of 11.63, a price-to-earnings-growth ratio of 0.96 and a beta of 0.29. The company has a fifty day simple moving average of $283.58 and a two-hundred day simple moving average of $281.51. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68.
Cigna Group Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be given a dividend of $1.56 per share. The ex-dividend date is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. Cigna Group’s dividend payout ratio is 25.82%.
Insider Buying and Selling
In other news, insider Nicole S. Jones sold 2,677 shares of the firm’s stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total value of $748,515.97. Following the completion of the sale, the insider directly owned 25,880 shares of the company’s stock, valued at $7,236,306.80. This trade represents a 9.37% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the stock in a transaction on Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the sale, the chief accounting officer owned 2,368 shares in the company, valued at $707,108.48. The trade was a 27.52% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 23,012 shares of company stock worth $6,386,550. Company insiders own 0.60% of the company’s stock.
Wall Street Analyst Weigh In
Several research analysts have commented on the stock. Guggenheim increased their price objective on shares of Cigna Group from $338.00 to $361.00 and gave the company a “buy” rating in a report on Friday, July 31st. Robert W. Baird set a $362.00 target price on Cigna Group in a report on Friday, July 31st. Morgan Stanley boosted their target price on Cigna Group from $355.00 to $361.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 20th. Deutsche Bank Aktiengesellschaft lowered Cigna Group from a “buy” rating to a “hold” rating and dropped their price target for the company from $303.00 to $302.00 in a research note on Wednesday, May 20th. Finally, The Goldman Sachs Group raised their price target on Cigna Group from $335.00 to $340.00 and gave the company a “buy” rating in a report on Monday, May 4th. Fifteen investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $339.45.
Check Out Our Latest Stock Report on Cigna Group
About Cigna Group
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Read More
- Five stocks we like better than Cigna Group
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
